HIV patients are at higher risk of heart attack

Image
IANS New York
Last Updated : Dec 22 2016 | 2:28 PM IST

In individuals with HIV, heart attack risk is nearly double than that of the general population, says a study.

"The actual risk of heart attack for people with HIV was roughly 50 per cent higher than predicted by the risk calculator many physicians use for the general population," said first author Matthew Feinstein from the Northwestern University Feinberg School of Medicine in Chicago, US.

The higher risk for heart attack -- about 1.5 to two times greater -- exists even in people whose virus is undetectable in their blood because of antiretroviral drugs, according to the study published in the journal JAMA Cardiology.

"There is chronic inflammation and viral replication even in people whose blood tests don't show any sign of the virus in the blood," Feinstein explained.

That is because the virus still lurks in the body's tissues, creating the inflammation that causes plaque buildup and can lead to a heart attack or a stroke.

Plaque build-up occurs 10 to 15 years earlier in HIV patients than in the uninfected population, the study said.

"It's this inflammatory state that seems to drive this accelerated ageing and these higher risks for heart disease, which are becoming more common in HIV patients as they live longer," Feinstein said.

For the study, the researchers analysed data from approximately 20,000 HIV-infected individuals.

They compared predicted rates of heart attacks based on data from the general population to the actual rates of heart attacks observed in this cohort and found that HIV patients have nearly twice the heart attack risk.

The scientists believe that primary driver of the higher risk was the HIV.

Accurately predicting an individual's risk helps determine whether he or she should take medications such as statins to reduce the risk of heart attack or stroke.

"If you have a higher risk for heart attack or stroke, your ability to benefit from one of these drugs is greater and justifies the possible side effects of a medication," Feinstein pointed out.

--IANS

gb/vt

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 22 2016 | 2:16 PM IST

Next Story